Short answer
Niagen Bioscience, Inc. (NAGE) filed an 8-K current report with the SEC on March 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q4 and full-year 2025 financial results announced March 4, 2026.
Niagen Bioscience, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q4 and full-year 2025 financial results announced March 4, 2026
- Actual figures in Exhibit 99.1 press release: key metrics not disclosed in this filing item
Item 7.01 · Regulation FD Disclosure
- Corporate presentation published March 4, 2026, now available on company website and filed as Exhibit 99.2
- Reg FD disclosure ensures all investors receive simultaneous access to material company information in the presentation
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Niagen Bioscience, Inc. 8-K filings
Get the next NAGE 8-K as it lands
Follow NAGE for push alerts, or ask the research agent what this filing means.